|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2000-6-15
|
|
pubmed:abstractText |
The optimal management of pregnancies at risk for neonatal alloimmune thrombocytopenia is debated. Proposed management includes the administration of intravenous immunoglobulin and serial determination of the fetal platelet count. The aims of our study were to determine the effectiveness and likely mechanism of action of intravenous immunoglobulin and to evaluate the safety of cordocentesis in cases of neonatal alloimmune thrombocytopenia.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0002-9378
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
182
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1233-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10819864-Antigens, Human Platelet,
pubmed-meshheading:10819864-Cordocentesis,
pubmed-meshheading:10819864-Female,
pubmed-meshheading:10819864-Fetal Blood,
pubmed-meshheading:10819864-Fetal Diseases,
pubmed-meshheading:10819864-Humans,
pubmed-meshheading:10819864-Immunoglobulins, Intravenous,
pubmed-meshheading:10819864-Infant, Newborn,
pubmed-meshheading:10819864-Isoantibodies,
pubmed-meshheading:10819864-Maternal-Fetal Exchange,
pubmed-meshheading:10819864-Platelet Count,
pubmed-meshheading:10819864-Pregnancy,
pubmed-meshheading:10819864-Thrombocytopenia,
pubmed-meshheading:10819864-Treatment Outcome,
pubmed-meshheading:10819864-Umbilical Veins
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Neonatal alloimmune thrombocytopenia: antenatal management.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
